Celgene Gives $10 Million to Myeloma Institute
The Myeloma Institute at the University of Arkansas for Medical Sciences (UAMS) has received a generous gift from Celgene Corporation to benefit patients with multiple myeloma through the creation of The Bart Barlogie Center for Molecular Diagnostics and the establishment of the Celgene Distinguished Endowed Chair in Molecular Therapeutics.
“This is an exciting, new collaboration between the Myeloma Institute and Celgene, bringing together leading institutions for consummate innovation in myeloma research,” said Gareth Morgan, M.D., Ph.D., director of the institute. “There has been a 57 percent increase in the total number of myeloma survivors since 2001 as a result of medical innovation. This is encouraging news for myeloma patients and our health care system but we can and must do better. The Bart Barlogie Center creates an exciting opportunity for the next generation of revolutionary transformation in myeloma care.
“The use and refinement of genomics and other novel diagnostic tools will enable development of precision medicine strategies aimed at targeting the distinct genetic signals that affect each patient’s disease. Through a deeper understanding of the molecular changes that take place in myeloma, the Myeloma Institute will be better equipped to identify the most appropriate drug therapies that will produce the best outcomes with minimal toxicity and that will make a cure truly achievable for the majority of patients,” Morgan said.
Nancy Gray Named Bioventures Director
Nancy M. Gray, Ph.D., has been named director of UAMS BioVentures, the technology licensing office and business incubator for the University of Arkansas for Medical Sciences (UAMS).
Gray replaces interim director Marie Chow, Ph.D., professor of microbiology and immunology and pathology, who led BioVentures during a search to replace Michael Douglas, Ph.D., who retired in 2012.
Gray has more than thirty years of experience in biomedical industries, including medicinal chemistry research, management of pharmaceutical research and development, and business operations.
Gray comes to UAMS from the Southern Research Institute in Birmingham, Alabama, where she was vice president for corporate development.